Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Colin P.N. Dinney"'
Autor:
Niyati Lobo, Graciela M. Nogueras-Gonzalez, Patrick J. Hensley, Colin P.N. Dinney, Kelly K. Bree, Ashish M. Kamat, Neema Navai
Publikováno v:
BJU internationalReferences. 130(4)
OBJECTIVE Previous reports attempting to evaluate the clinical efficacy of intravesical bacillus Calmette-Guerin (BCG) therapy in patients taking fibrin clot inhibitors (FCI) have yielded conflicting results and are primarily based on patient cohorts
Autor:
Young-Chul Kim, Scott M. Gilbert, Wade J. Sexton, Michael A. Poch, Colin P.N. Dinney, Jasreman Dhillon, Jingsong Zhang, James J. Mulé, Rohit Jain, Roger Li, G.D. Grass, Anders Berglund, Jose R. Conejo-Garcia, Julio M. Pow-Sang, Logan Zemp, Shari Pilon-Thomas, Ryan Putney
Publikováno v:
Journal of Clinical Oncology. 39:466-466
466 Background: Adaptive anti-tumor immunity can be orchestrated by lymph node-like immune cell aggregates within the tumor microenvironment (TME) called tertiary lymphoid structures (TLSs). TLSs are postulated to be the gateway of lymphocyte infiltr
Autor:
Colin P.N. Dinney, Gang Wang, Bogdan Czerniak, Miao Zhang, Arlene O. Siefker-Radtke, Ashish M. Kamat, Li Xiao, Charles C. Guo
Summary Small cell carcinoma (SmCC) of the bladder is a rare disease. We retrospectively studied a large series of bladder SmCC from a single institution. The patients included 69 men and 12 women with a mean age of 68 years. Most bladder SmCCs were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304bdebda7534836a1fb1f4891e32236
https://europepmc.org/articles/PMC6133751/
https://europepmc.org/articles/PMC6133751/
Autor:
David J. McConkey, Giovanni Nitti, Neema Navai, Bogdan Czerniak, Tiewei Cheng, Colin P.N. Dinney, Debasish Sundi, Jonathan Melquist, Isuru Jayaratna, Sima P. Porten, Beat Roth, Charles C. Guo, Woonyoung Choi, Matthew F. Wszolek
Publikováno v:
Roth, Beat; Jayaratna, Isuru; Sundi, Debasish; Cheng, Tiewei; Melquist, Jonathan; Choi, Woonyoung; Porten, Sima; Nitti, Giovanni; Navai, Neema; Wszolek, Matthew; Guo, Charles; Czerniak, Bogdan; McConkey, David; Dinney, Colin (2017). Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. OncoTarget, 8(21), pp. 34205-34222. Impact Journals LLC 10.18632/oncotarget.11009
Oncotarget, vol. 8, no. 21, pp. 34205-34222
Oncotarget
Oncotarget, vol. 8, no. 21, pp. 34205-34222
Oncotarget
Epithelial-to-mesenchymal transition (EMT) has been implicated in the progression of bladder cancer. To study its contribution to bladder cancer metastasis, we established new xenograft models derived from human bladder cancer cell lines utilizing an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f67ac40adab9d0a9896ed1530f170f
Autor:
Takeshi Nagai, Kentaro Sakamaki, Afsaneh Keyhani, Koji Tsuta, Jolanta Bondaruk, Ashish M. Kamat, Colin P.N. Dinney, Bogdan Czerniak, Hisashi Oshiro
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Recent tissue microarray (TMA)-based studies have shown that cell proliferation- and apoptosis-related biomarkers are associated with clinical outcomes in patients with bladder urothelial car
Recent tissue microarray (TMA)-based studies have shown that cell proliferation- and apoptosis-related biomarkers are associated with clinical outcomes in patients with bladder urothelial car
Publikováno v:
Bladder cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42636b540f0187207434f55607bb7a72
https://doi.org/10.1002/9781118674826.ch31
https://doi.org/10.1002/9781118674826.ch31
Autor:
Mark P. Purdue, Margaret R. Karagas, Seth P. Lerner, Joseph F. Fraumeni, W. Ryan Diver, Jie Lin, Alison Johnson, Colin P.N. Dinney, Josep Lloreta, Debra T. Silverman, Francisco X. Real, Núria Malats, Amanda Black, Immaculata De Vivo, Xia Pu, Molly Schwenn, Gerald L. Andriole, Meredith Yeager, Stephanie J. Weinstein, Reina Garcia-Closas, Laurie Burdett, Jian Gu, Alfredo Carrato, H. Barton Grossman, Neil E. Caporaso, Dalsu Baris, Jarmo Virtamo, Montserrat Garcia-Closas, Consol Serra, Stephen J. Chanock, Xifeng Wu, Yuanqing Ye, Yi-Ping Fu, Alan R. Schned, Michael J. Thun, Adonina Tardón, Zhaoming Wang, Manolis Kogevinas, Ludmila Prokunina-Olsson, Robert L. Grubb, Amy Hutchinson, Maria Teresa Landi, Susan M. Gapstur, Eric J. Jacobs, Demetrius Albanes, Kevin B. Jacobs, Nilanjan Chatterjee, David J. Hunter, Ashish M. Kamat, Wei Tang, Nathaniel Rothman, Jonine D. Figueroa
Publikováno v:
Human Molecular Genetics; Vol 20
Genome-wide and candidate-gene association studies of bladder cancer have identified 10 susceptibility loci thus far. We conducted a meta-analysis of two previously published genome-wide scans (4501 cases and 6076 controls of European background) and
Autor:
Liana Adam, Lauren Marquis, Woonyoung Choi, David J. McConkey, Michael B. Williams, Frances M Martin, Ashish M. Kamat, Arlene O. Siefker-Radtke, Jay B. Shah, Aditi Das, Robert S. Svatek, Colin P.N. Dinney
Publikováno v:
Cancer and Metastasis Reviews. 28:335-344
Epithelial-to-mesenchymal transition (EMT) is a process that plays essential roles in development and wound healing that is characterized by loss of homotypic adhesion and cell polarity and increased invasion and migration. At the molecular level, EM
Autor:
Milena S. Nicoloso, George A. Calin, Meng Zhong, Ameeta Arora, Arlene O. Siefker-Radtke, Wei Qi, Menashe Bar-Eli, Hua Wang, Liana Adam, David J. McConkey, Woonyoung Choi, Colin P.N. Dinney
Publikováno v:
Clinical Cancer Research. 15:5060-5072
Purpose: The epithelial-to-mesenchymal transition (EMT) is a cell development-regulated process in which noncoding RNAs act as crucial modulators. Recent studies have implied that EMT may contribute to resistance to epidermal growth factor receptor (
Autor:
Wassim Kassouf, Teruo Inamoto, Peter C. Black, Mark B. Fisher, David Gallagher, David J. McConkey, Colin P.N. Dinney, Gordon A. Brown, Liana Adam, Tony Luongo, Menashe Bar-Eli
Publikováno v:
Journal of Urology. 180:1146-1153
The epidermal growth factor receptor inhibitor gefitinib (Iressa) is currently being studied in patients with bladder cancer and it has significant anti-angiogenic activity. We investigated the relationship between the modulation of vascular endothel